<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2797">Prospective cohort study at Oslo University Hospital, Oslo, Norway, between September 8, 2010, and January 13, 2014. Resuscitated comatose OHCA patients admitted to an intensive care unit were included. Patients were treated according to a standardized treatment protocol including therapeutic hypothermia to 33 °C for 24 hours. CKD and AKI were classified according to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines. Patients with previously known CKD were excluded from further detailed analyses. Main outcomes were six-months mortality and good neurological outcome defined as Cerebral Performance Category 1-2.</p>
